Pricing

XNK Therapeutics

13 people · 0 jobs

‌

XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.

Industries

Pharmaceutical

Headquarters

Huddinge, Sweden

Employees

11-50

Links

Org chart

Hans Ericson

Chief Financial Officer

Stephan Meinke

Head of R&D

Michael Uhlin

Chief Scientific Officer

Julia Remnestål

Regulatory Affairs Manager

Paul Do

Head of Clinical Manufacturing and Engineering

Zahra Rajabkhani

Production Lead

Anton Törnqvist Andrén

Scientist

Karin Mellström

Senior Project Manager

Board & advisors

Lena Degling Wikingsson

Chairman

Gunnar Mattsson

Director

Hans Gustaf Ljunggren

Director

Agneta Edberg

Director

Vera Franzén

Regulatory Advisor

Teams

Research and Development

6 people · 0 jobs

Leadership Team

2 people · 0 jobs

Offices

HQ
0 people · 0 jobs

Similar companies

Oncopeptides

2 followers

Arthritis Knee Pain Centers

2 followers

AstraZeneca

432 followers

Bayer

358 followers

Bristol-Myers Squibb

264 followers

UCB

56 followers

Astellas Pharma

42 followers

NYU Langone Health

31 followers

Tilray

19 followers

Perrigo

16 followers

Spotify

1386 followers

Explore companies